Assessment of the FDA TPL Review for ZYN PMTA

The FDA’s review of ZYN nicotine pouch PMTAs found Swedish Match submitted a strong application, confirming low toxicant levels and low abuse liability. While approval was granted, the case signals that future PMTAs will face stricter requirements such as extractables and leachables data, cancer risk calculations, and more robust abuse liability evidence.